top of page


Registration Open for Eyecelerator, a New Conference Accelerating Eye Care Advancements


Harvard Business School innovation expert to keynote inaugural conference


SAN FRANCISCO – Feb. 27, 2020 – Registration is now open for Eyecelerator, a next-generation business conference to further ophthalmic innovation. The conference is a joint venture between the American Academy of Ophthalmology and ASCRS (American Society of Cataract and Refractive Surgery), the two largest and most respected societies in ophthalmology. The inaugural Eyecelerator conference will be held on May 14 in Boston, in conjunction with the ASCRS annual meeting. The second Eyecelerator conference will be in November, in conjunction with the Academy’s annual meeting in Las Vegas.


Leaders from both organizations have created a conference that engages in unique ways inventors, investors, scientists, physicians, entrepreneurs, startups and established businesses. Showcasing emerging technology, groundbreaking research and inventive concepts, the conference will act as the catalyst that propels innovation, transforming the future of ophthalmology. 


The inaugural conference will feature a keynote address from Harvard Business School Professor Gary P. Pisano, a noted authority on the management of innovation and competitive strategy. His research and consulting experience span a range of industries, including biotechnology, pharmaceutical, healthcare, aerospace and technology.


“We’re designing a dynamic schedule of programs focused on advancing state-of-the-art eye care at all stages of development, from emerging to market-ready, from VC-backed concepts to those seeking investors,” said Eric D. Donnenfeld, MD, program co-chair. “We are also creating face-to-face and digital networking opportunities to create meaningful connections between attendees.”



Eyecelerator Conference I

Sheraton Boston

May 14, 2020

General – $600

ASCRS/Academy Members – $300


The one-day conference program includes presentations on:

  • Innovation for unmet clinical needs

  • Developing new category marketplaces

  • Recent clinical and financial milestones in innovation

  • Real world data: IRIS + MIGS

  • Combination product approvals

  • New markets, technology and capital sources outside the US

  • Wall Street view of ophthalmology markets

  • Pathways for growth from the next-generation strategics

  • Where innovation fits into industry consolidation


Complete and updated program and presenter information can be found at



Alcon, Allergan, J+J Vision, Santen Pharmaceuticals, Ltd., STAAR Surgical and Zeiss are Major Founding Sponsors of both 2020 Eyecelerator conferences. Additional sponsors include:

  • Aerie

  • Bausch + Lomb

  • BVI

  • CorneaGen

  • Eyenovia

  • EyePoint Pharmaceuticals

  • Glaukos

  • Neurotech

  • Ocular Therapeutix


  • SVB Leerink

  • Trefoil Therapeutics

  • William Blair

About Eyecelerator

Eyecelerator, originally called Ophthovation, is a partnership between ASCRS (American Society of Cataract and Refractive Surgery) and the American Academy of Ophthalmology to connect entrepreneurs, investors, businesses and ophthalmologists to accelerate ophthalmic innovation and improve patient outcomes. For more information, visit


ASCRS is an international educational society with nearly 8,000 ophthalmic surgeons at every career stage. Its mission is to empower anterior segment surgeons to improve the vision, outcomes and quality of life for their patients through innovative approaches to education, advocacy and philanthropy. For more information, visit

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit

bottom of page